Free tool
FAERS Monitor: Tekturna
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021985 or its brand name (Tekturna, Aliskiren Hemifumarate). Reports on generic versions are filed under their own applications.
Reports
6,026
Serious
4,257
71% of reports
Hospitalization
1,934
Death reported
746
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea666
- blood pressure increased626
- fatigue617
- headache616
- fall594
- asthenia587
- cough543
- dizziness541
- dyspnoea529
- malaise527
- vomiting470
- diarrhoea463
- pyrexia421
- cerebrovascular accident408
- drug ineffective375
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 628 |
| 2008 | 728 |
| 2009 | 285 |
| 2010 | 384 |
| 2011 | 607 |
| 2012 | 734 |
| 2013 | 401 |
| 2014 | 254 |
| 2015 | 272 |
| 2016 | 233 |
| 2017 | 121 |
| 2018 | 223 |
| 2019 | 195 |
| 2020 | 145 |
| 2021 | 90 |
| 2022 | 152 |
| 2023 | 120 |
| 2024 | 206 |
| 2025 | 155 |
| 2026 | 93 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,133 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood pressure increasedSignal | 626 | 14.3 | 13.3 | 7,784 |
| cerebrovascular accidentSignal | 408 | 8.4 | 7.7 | 2,677 |
| coughSignal | 543 | 6.8 | 6.2 | 2,695 |
| fallSignal | 594 | 6.2 | 5.8 | 2,645 |
| astheniaSignal | 587 | 5.5 | 5.1 | 2,167 |
| pyrexiaSignal | 421 | 4.3 | 3.9 | 1,059 |
| malaiseSignal | 527 | 4.2 | 3.9 | 1,306 |
| dizzinessSignal | 541 | 3.8 | 3.5 | 1,133 |
| vomitingSignal | 470 | 3.5 | 3.2 | 851 |
| headacheSignal | 616 | 3.4 | 3.2 | 1,090 |
| dyspnoeaSignal | 529 | 3.3 | 3.0 | 850 |
| nauseaSignal | 666 | 2.9 | 2.7 | 882 |
| fatigueSignal | 617 | 2.8 | 2.6 | 721 |
| diarrhoeaSignal | 463 | 2.5 | 2.3 | 430 |
| drug ineffective | 375 | 1.0 | 0.9 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.